Literature DB >> 22986222

[Questionnaire survey of air extruded jelly dosage form (I) - oral condition of elder patients and applicability of air extruded jelly formulation - ].

Takehisa Hanawa1, Noboru Tokutake, Toshio Oguchi.   

Abstract

Elderly patients tend to have troubles with oral conditions such as the impairment of deglutition capability (difficulty in swallowing), in addition to a decline in physical performance. An air extruded jelly formulation (AEJF) has been developed as a new formulation consisting of jelly and clean air under increased pressure. As jelly is discharged smoothly by pushing the air portion, elderly patients are able to easily take jelly from the package. In this study, survey questionnaires after a patient's trial of AEJF were conducted to characterize the intra-oral condition and reveal the applicability of AEJF in elderly patients. The subjects were 108 patients (ranging in age from 50 to 79) with chronic diseases who take some oral medicine regularly. A questionnaire on the oral state and compliance level was conducted before the trial of AEJF. The ratios of subjects with deglutition impairment and dryness of the mouth were 29.7% and 36.1%, respectively. Non-compliance was observed in 31.5% of the subjects. After the trial using AEJF, 94.5% of subjects felt that AEJF was easy to swallow. The ratio of the patients expecting AEJF to be an oral formulation was 89.3%, and those with an intention of daily use was 83.4%. A majority of the subjects, 63.9%, intended to switch their present formulations to AEJF. Especially, a high ratio was found among subjects who presently take a powder formulation or more than 5 kinds of medicines daily. Based on these results, AEJF is expected to improve the adherence of elderly patients to their medicine dosage regimens, and to improve compliance among those with oral troubles or some other hindrance to compliance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986222     DOI: 10.1248/yakushi.y110167

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  2 in total

1.  Swallowing difficulties with medication intake assessed with a novel self-report questionnaire in patients with systemic sclerosis - a cross-sectional population study.

Authors:  Markus Messerli; Rebecca Aschwanden; Michael Buslau; Kurt E Hersberger; Isabelle Arnet
Journal:  Patient Prefer Adherence       Date:  2017-09-28       Impact factor: 2.711

Review 2.  Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation.

Authors:  Kazuhiro Imai
Journal:  Clin Interv Aging       Date:  2013-06-07       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.